Trials / Unknown
UnknownNCT03793322
The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Zhujiang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the feasibility of indocyanine green (ICG)-based fluorescence imaging in the detection of liver tumors. By correlating the ICG fluorescence patterns with pathologically confirmed tumors , it would be possible to use fluorescence navigation system in helping promoting oncology treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indocyanine-Green(ICG) | ICG was administered intravenously 24 hours before the operation , or directly into the portal vein branches supplying the tumor-bearing hepatic segment, after puncturing of the target segments under intraoperative ultrasonography guidance. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2020-01-01
- Completion
- 2020-12-31
- First posted
- 2019-01-04
- Last updated
- 2019-01-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03793322. Inclusion in this directory is not an endorsement.